
CAS 1217546-82-1
:Vildagliptin-d3
CAS:Produto ControladoStability Hygroscopic
Applications Labelled Vildagliptin. It is a new oral anti-hyperglycemic agent of a new dipeptidyl peptidase-IV (DPP-IV) inhibitor class of drugs. Antidiabetic.
References Ahren, B., et al.: J. Clin. Endocrinol. Metab., 89, 2078 (2004), Ahren, B., et al.: Diabetes Care, 27, 2874 (2004), Barlocco, D., et al.: Curr. Opin. Invest. Drugs, 5, 1094 (2004),Fórmula:C17H22D3N3O2Cor e Forma:NeatPeso molecular:306.42Vildagliptin-d3
CAS:Vildagliptin-d3 is an analog of the drug Vildagliptin, which is a potent inhibitor of kinases. This drug has been shown to have anticancer properties and may be useful in the treatment of various types of cancer. Vildagliptin-d3 has been tested on Chinese hamster ovary cells and human cancer cell lines, where it demonstrated potent inhibition of tumor growth and induced apoptosis. This drug is also a potent inhibitor of protein kinases, which are involved in many cellular processes such as cell growth and differentiation. Additionally, Vildagliptin-d3 has been found in urine samples from patients treated with nifedipine, suggesting that it may be useful in the diagnosis or monitoring of certain conditions.
Fórmula:C17H25N3O2Pureza:Min. 95%Peso molecular:306.42 g/mol


